Evotec - Research never stops
  • Loading...
Evotec.com

Top Story

Ad hoc: Evotec Strengthens Discovery Alliance Business through Acquisition of DeveloGen

Ad hoc: Evotec and Boehringer Ingelheim Extend and Broaden Research Collaboration

Ad hoc: Evotec starts Phase I with EVT 103, an NR2B-selective NMDA receptor antagonist

Request Information

Services and Partnering Opportunities
Investor Relations/Public Relations
loading weather report
Loading weather report...

Events

Sep 01, 2010 - NGP Europe Summit 2010

- more Events

Aug 12, 2010 - Half Year Report 2010

- more Events

Company Presentation July

Building integrated and high value drug discovery alliances
Evotec_CompanyPresentation_
English_July... (826,81 kB)

Want to read some older articles?
- visit the archive